DOI QR코드

DOI QR Code

Endoscopic ultrasound-guided tissue acquisition for personalized treatment in pancreatic adenocarcinoma

  • Sang Myung Woo (Research Institute, Center for Liver and Pancreatobiliary Cancer, National Cancer Center)
  • Received : 2023.01.30
  • Accepted : 2023.03.01
  • Published : 2023.03.30

Abstract

Keywords

References

  1. Hyeon DY, Nam D, Han Y, et al. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes. Nat Cancer 2023;4:290-307.
  2. O'Kane GM, Lowery MA. Moving the needle on precision medicine in pancreatic cancer. J Clin Oncol 2022;40:2693-2705.
  3. Chung MJ, Park SW, Kim SH, et al. Clinical and technical guideline for endoscopic ultrasound (EUS)-guided tissue acquisition of pancreatic solid tumor: Korean Society of Gastrointestinal Endoscopy (KSGE). Clin Endosc 2021;54:161-181.
  4. Kandel P, Nassar A, Gomez V, et al. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial. Endoscopy 2021;53:376-382.
  5. Park JK, Lee JH, Noh DH, et al. Factors of endoscopic ultrasound-guided tissue acquisition for successful next-generation sequencing in pancreatic ductal adenocarcinoma. Gut Liver 2020; 14:387-394.
  6. Okuno N, Hara K, Mizuno N, et al. Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of pancreatic cancer. Clin Endosc 2023;56:221-228.
  7. Roy-Chowdhuri S, Goswami RS, Chen H, et al. Factors affecting the success of next-generation sequencing in cytology specimens. Cancer Cytopathol 2015;123:659-668.